{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:20:04Z","timestamp":1790382004886,"version":"4.1.0"},"reference-count":119,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Microbiol Rev"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:p>Research in visceral leishmaniasis in the last decade has been focused on how better to use the existing medicines as monotherapy or in combination. Systematic research by geographical regions has shown that a universal treatment is far from today's reality.<\/jats:p>","DOI":"10.1128\/cmr.00048-18","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T09:30:43Z","timestamp":1535448643000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":182,"title":["Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives"],"prefix":"10.1128","volume":"31","author":[{"given":"Fabiana","family":"Alves","sequence":"first","affiliation":[{"name":"Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Bilbe","sequence":"additional","affiliation":[{"name":"Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Blesson","sequence":"additional","affiliation":[{"name":"Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Goyal","sequence":"additional","affiliation":[{"name":"Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Monnerat","sequence":"additional","affiliation":[{"name":"Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Mowbray","sequence":"additional","affiliation":[{"name":"Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Muthoni Ouattara","sequence":"additional","affiliation":[{"name":"Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"P\u00e9coul","sequence":"additional","affiliation":[{"name":"Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Rijal","sequence":"additional","affiliation":[{"name":"Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joelle","family":"Rode","sequence":"additional","affiliation":[{"name":"Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Solomos","sequence":"additional","affiliation":[{"name":"Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Strub-Wourgaft","sequence":"additional","affiliation":[{"name":"Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Wasunna","sequence":"additional","affiliation":[{"name":"Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Wells","sequence":"additional","affiliation":[{"name":"Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard E.","family":"Zijlstra","sequence":"additional","affiliation":[{"name":"Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron","family":"Arana","sequence":"additional","affiliation":[{"name":"Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Alvar","sequence":"additional","affiliation":[{"name":"Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","volume-title":"Control of the leishmaniases. Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases","author":"WHO","year":"2010","unstructured":"WHO. 2010. Control of the leishmaniases. Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases. Technical Report Series 949. World Health Organization, Geneva, Switzerland. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/44412\/WHO_TRS_949_eng.pdf?sequence=1."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2006.09.004"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003021"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12556"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003136"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005877"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(03)00517-6"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035671"},{"key":"e_1_3_2_10_2","unstructured":"WHO. 3 June 2016. Leishmaniasis in high-burden countries: an epidemiological update based on data reported in 2014. Wkly Epidemiol Rec. 91:285\u2013296. http:\/\/www.who.int\/neglected_diseases\/resources\/who_wer9122\/en\/."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis716"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009135.pub2"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1748"},{"key":"e_1_3_2_14_2","first-page":"1","article-title":"The treatment of kala-azar\u2013new approaches to an old problem","volume":"73","author":"Peters W","year":"1981","unstructured":"Peters W. 1981. The treatment of kala-azar\u2013new approaches to an old problem. Indian J Med Res 73(Suppl):1\u201318.","journal-title":"Indian J Med Res"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1086\/318121"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(03)90167-2"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(99)90037-8"},{"key":"e_1_3_2_18_2","volume-title":"Regional Office for South-East Asia, Department of Communicable Diseases","author":"WHO","year":"2005","unstructured":"WHO. 2005. Regional strategic framework for elimination of kala-azar from the South-East Asia region (2005-2015). SEA-VBC-85 (Rev-1). Regional Office for South-East Asia, Department of Communicable Diseases, World Health Organization, New Delhi, India. http:\/\/apps.searo.who.int\/pds_docs\/b0211.pdf."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021556"},{"key":"e_1_3_2_20_2","unstructured":"Sundar S Murray HW. 2005. Availability of miltefosine for the treatment of kala-azar in India. Bull World Health Organ 83:394\u2013395. http:\/\/europepmc.org\/abstract\/MED\/15976883."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis474"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit102"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu039"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-017-1969-z"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1080\/00034983.1968.11686529"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa066536"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00707-15"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.30.6.847"},{"key":"e_1_3_2_29_2","first-page":"179","article-title":"Effect of tissue penetration on AmBisome efficacy","volume":"4","author":"Adler-Moore J","year":"2003","unstructured":"Adler-Moore J, Proffitt RT. 2003. Effect of tissue penetration on AmBisome efficacy. Curr Opin Investig Drugs 4:179\u2013185.","journal-title":"Curr Opin Investig Drugs"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(96)90271-0"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000764"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2002.66.143"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1086\/507530"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0903627"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70320-0"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(13)70118-9"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002603"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.2001.00795.x"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62050-8"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005635"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2011.10-0661"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1086\/519690"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2011.10-0321"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-015-0987-y"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000709"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2007.77.89"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001674"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-016-0481-0"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/tmi.12603"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002613"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000855"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004880"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(01)90218-4"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1948-7134.2011.00109.x"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1179\/000349802125002211"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000889"},{"key":"e_1_3_2_57_2","unstructured":"Reference deleted."},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(05)70296-6"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2010.10-0156"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-015-0909-z"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-308X(04)57001-X"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-10-342"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2007.01998.x"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2011.04.001"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002725"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES2013.18.30.20546"},{"key":"e_1_3_2_67_2","volume-title":"Leishmaniases Report 5","author":"Pan American Health Organization","year":"2017","unstructured":"Pan American Health Organization. 2017. Leishmaniases: epidemiological report of the Americas. Leishmaniases Report 5. Pan American Health Organization, Washington, DC. http:\/\/iris.paho.org\/xmlui\/handle\/123456789\/34112."},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093770"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005706"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1590\/0037-8682-0455-2016"},{"key":"e_1_3_2_71_2","first-page":"25","article-title":"Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries","volume":"76","author":"Berman JD","year":"1998","unstructured":"Berman JD, Badaro R, Thakur CP, Wasunna KM, Behbehani K, Davidson R, Kuzoe F, Pang L, Weerasuriya K, Bryceson ADM. 1998. Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries. Bull World Health Organ 76:25\u201332. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2305623\/pdf\/bullwho00001-0028.pdf.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_2_72_2","volume-title":"WHO Regional Office for Europe","author":"Ejov M","year":"2014","unstructured":"Ejov M, Dagne D. 2014. Strategic framework for leishmaniasis control in the WHO European Region 2014-2020. WHO Regional Office for Europe, World Health Organization, Copenhagen, Denmark. http:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0017\/245330\/Strategic-framework-for-leishmaniasis-control-in-the-WHO-European-Region-20142020.pdf?ua=1."},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.2807\/ese.15.10.19505-en"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00061-07"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004179"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0133-0"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2008.02144.x"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000814"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/22.6.938"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1086\/367843"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001602"},{"key":"e_1_3_2_82_2","volume-title":"Fexinidazole\/miltefosine combination (VL)","author":"DNDi","year":"2016","unstructured":"DNDi. August 2016. Fexinidazole\/miltefosine combination (VL). Drugs for Neglected Diseases initiative, Geneva, Switzerland. https:\/\/www.dndi.org\/diseases-projects\/portfolio\/completed-projects\/fexinidazole-vl\/. Accessed 11 January 2018."},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2014.09.006"},{"key":"e_1_3_2_84_2","volume-title":"VL-2098","author":"DNDi","year":"2015","unstructured":"DNDi. October 2015. VL-2098. Drugs for Neglected Diseases initiative, Geneva, Switzerland. https:\/\/www.dndi.org\/diseases-projects\/portfolio\/completed-projects\/vl-2098\/. Accessed 11 January 2018."},{"key":"e_1_3_2_85_2","volume-title":"DNDI-0690","author":"DNDi","year":"2018","unstructured":"DNDi. March 2018. DNDI-0690. Drugs for Neglected Diseases initiative, Geneva, Switzerland. https:\/\/www.dndi.org\/diseases-projects\/portfolio\/nitroimidazole. Accessed 11 January 2018."},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005971"},{"key":"e_1_3_2_87_2","volume-title":"DNDi-6148","author":"DNDi","year":"2018","unstructured":"DNDi. March 2018. DNDi-6148. Drugs for Neglected Diseases initiative, Geneva, Switzerland. https:\/\/www.dndi.org\/diseases-projects\/portfolio\/oxaborole-dndi-6148\/. Accessed 11 January 2018."},{"key":"e_1_3_2_88_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature19339"},{"key":"e_1_3_2_89_2","unstructured":"Supek F Nagle A Molteni V Glynne R. 2017. Discovery and optimisation of a new class of potent antileishmanial compound and determination of their mechanism of action session 14.4 p 50. In 6th World Congress on Leishmaniasis (WorldLeish-6) Abstracts Book. http:\/\/worldleish2017.org\/documentos\/Abstracts_Book_WL6_2017.pdf."},{"key":"e_1_3_2_90_2","unstructured":"Reference deleted."},{"key":"e_1_3_2_91_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0356-z"},{"key":"e_1_3_2_92_2","unstructured":"Wyllie S. 2017. DDD853651 a pre-clinical candidate for visceral leishmaniasis acts through inhibition of cyclin-dependent kinase 12 abstr C0456 p 875. In 6th World Congress on Leishmaniasis (WorldLeish-6) Abstracts Book. http:\/\/worldleish2017.org\/documentos\/Abstracts_Book_WL6_2017.pdf."},{"key":"e_1_3_2_93_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b01456"},{"key":"e_1_3_2_94_2","volume-title":"Aminopyrazoles","author":"DNDi","year":"2018","unstructured":"DNDi. March 2018. Aminopyrazoles. Drugs for Neglected Diseases initiative, Geneva, Switzerland. https:\/\/www.dndi.org\/diseases-projects\/portfolio\/aminopyrazoles. Accessed 11 January 2018."},{"key":"e_1_3_2_95_2","volume-title":"CGH VL series 1","author":"DNDi","year":"2018","unstructured":"DNDi. March 2018. CGH VL series 1. Drugs for Neglected Diseases initiative, Geneva, Switzerland. https:\/\/www.dndi.org\/diseases-projects\/portfolio\/chgvl-series-1. Accessed 11 January 2018."},{"key":"e_1_3_2_96_2","doi-asserted-by":"publisher","DOI":"10.1517\/17460441.2013.807247"},{"key":"e_1_3_2_97_2","volume-title":"South-East Asia poised to defeat visceral leishmaniasis (kala-azar)","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. 19 October 2015. South-East Asia poised to defeat visceral leishmaniasis (kala-azar). WHO, Geneva, Switzerland. http:\/\/www.who.int\/neglected_diseases\/news\/SEARO_poised_to_defeat_VL\/en\/."},{"key":"e_1_3_2_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30140-2"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-016-1309-8"},{"key":"e_1_3_2_100_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00103-8"},{"key":"e_1_3_2_101_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001405"},{"key":"e_1_3_2_102_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003966"},{"key":"e_1_3_2_103_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1125-3"},{"key":"e_1_3_2_104_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006264"},{"key":"e_1_3_2_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70011-6"},{"key":"e_1_3_2_106_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100220"},{"key":"e_1_3_2_107_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix245"},{"key":"e_1_3_2_108_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.16-0883"},{"key":"e_1_3_2_109_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2006.01589.x"},{"key":"e_1_3_2_110_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0031182099004680"},{"key":"e_1_3_2_111_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(01)90223-8"},{"key":"e_1_3_2_112_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2010.02629.x"},{"key":"e_1_3_2_113_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/25.4.862"},{"key":"e_1_3_2_114_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002720"},{"key":"e_1_3_2_115_2","unstructured":"den Boer M Herrero M Lado M Alatiaby A Ochol D Adera C Pachl H Alvar J Yirga A Mekonen B Ritmeijer K. Clinical mentoring by mobile teams\u2014a new approach to visceral leishmaniasis care in resource-constrained settings in East Africa abstr C1847 p 379. In 6th World Congress on Leishmaniasis (WorldLeish-6) Abstracts Book. http:\/\/worldleish2017.org\/documentos\/Abstracts_Book_WL6_2017.pdf."},{"key":"e_1_3_2_116_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0036-46652015000100005"},{"key":"e_1_3_2_117_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2014.05.010"},{"key":"e_1_3_2_118_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetpar.2011.05.009"},{"key":"e_1_3_2_119_2","doi-asserted-by":"publisher","DOI":"10.1177\/2049936116646063"},{"key":"e_1_3_2_120_2","unstructured":"World Health Assembly. 2007. WHA 60.13 Control of leishmaniasis. http:\/\/www.who.int\/neglected_diseases\/mediacentre\/WHA_60.13_Eng.pdf."}],"container-title":["Clinical Microbiology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CMR.00048-18","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CMR.00048-18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T13:00:31Z","timestamp":1645621231000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CMR.00048-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":119,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1128\/CMR.00048-18"],"URL":"https:\/\/doi.org\/10.1128\/cmr.00048-18","relation":{},"ISSN":["0893-8512","1098-6618"],"issn-type":[{"value":"0893-8512","type":"print"},{"value":"1098-6618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"2018-08-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00048-18"}}